Results 221 to 230 of about 411,361 (311)

Adverse drug reactions, particularly liver disorders, drive interruptions in anti‐tuberculosis treatment: A retrospective cohort study

British Journal of Clinical Pharmacology, EarlyView.
Aims Adverse drug reactions (ADRs) are a key driver of missed doses of anti‐tuberculosis (TB) therapy. We aimed to determine the relative burden of ADR‐driven missed doses, the missed dose patterns associated with ADRs, and the association between specific ADRs and missed doses.
Eleanor G. Dixon, Evita Biraua, Edvards Brencsēns, Vitālijs Pašuks, Vija Riekstina, Anete Šperberga, Marisa D. Muckian, James W. Dear, Liga Kuksa, Derek J. Sloan, Helen R. Stagg   +10 more
wiley   +1 more source

Cancer caregiving burden trajectory over time: perceived versus objectively measured burden. [PDF]

Oncologist
Kajiwara K, Kako J, Kobayashi M, Ito Y, Tsubaki M, Yamanaka M, Sakuramoto H, Kakeda T.   +7 more
europepmc   +1 more source

Assessment of the teaching-learning process: its meaning for students holding a high school diploma or equivalent and attending a nursing program

, 2002
Marcos Antônio da Eira Frias, Regina Toshie Takahashi   +1 more
openalex  

Quality indicators for safe and effective use of medications in long‐term care settings: A systematic review

British Journal of Clinical Pharmacology, EarlyView.
People accessing aged care services are increasingly older and often experience multimorbidity and polypharmacy, which puts them at risk of medication‐related harm. Quality indicators (QIs) can assist with monitoring, benchmarking and informing initiatives to reduce medication‐related harm.
Daria S. Gutteridge, Annabel H. Calder, Jacquelina Stasinopoulos, Sara Javanparast, Gillian E. Caughey, Jodie B. Hillen, Andrew C. Stafford, Gregory M. Peterson, Maria C. Inacio, Jyoti Khadka, Lisa M. Kalisch Ellett, Shane L. Jackson, Peter D. Hibbert, Monica L. Cations, Megan E. Corlis, Solomon C. Yu, Malcom J. Clark, Natalie R. Soulsby, Elizabeth Manias, Grace H.‐Y. Yoo, Janet K. Sluggett   +20 more
wiley   +1 more source

Protecting Dignity in Intimate Nursing Care. [PDF]

Iran J Nurs Midwifery Res
Zolkefli Y, Isahak FH.
europepmc   +1 more source

Using non‐linear slide decks to administer individualized problem‐based learning assessments within pharmacology education

British Journal of Clinical Pharmacology, EarlyView.
Aim Problem‐based learning (PBL) is an established approach in medical, nursing, pharmacy and veterinary medicine education. This study describes the implementation and aims to evaluate the use of non‐linear slide decks as a method to deliver PBL as individualized student assessments within pharmacology education. This approach, originally developed in
Wendy R. Francis, Nia A. Davies, Aidan Seeley   +2 more
wiley   +1 more source

Life skills that promote school health in adolescents: a concept analysis. [PDF]

BMC Public Health
Torres DG, Romero AMO, Fuentes-Ramírez A.   +2 more
europepmc   +1 more source

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

British Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun, Jingrong Yang, Lei Wan, Xia Xu, Jing Wang   +4 more
wiley   +1 more source

<i>Healthcare</i> Reloaded: Announcing the New Aims and Scope of <i>Healthcare</i>. [PDF]

Healthcare (Basel)
Evangelista LS.
europepmc   +1 more source

Population pharmacokinetics of artemether–lumefantrine plus amodiaquine in patients with uncomplicated Plasmodium falciparum malaria

British Journal of Clinical Pharmacology, EarlyView.
Aims Resistance to the artemisinins and the artemisinin‐based combination therapy (ACT) partner drugs has developed in Southeast Asia, and artemisinin resistance has also emerged in eastern Africa. Triple ACTs (triple artemisinin‐based combination therapies, TACT), consisting of two partner drugs with different mechanisms of action and similar ...
Junjie Ding, Richard M. Hoglund, Rob W. van der Pluijm, James J. Callery, Thomas J. Peto, Rupam Tripura, Sukanta Das, Nguyễn Hoàng Châu, Cholrawee Promnarate, Mavuto Mukaka, Lek Dysoley, Caterina Fanello, Marie A. Onyamboko, Anupkumar R. Anvikar, Mayfong Mayxay, Frank Smithuis, Lorenz von Seidlein, Mehul Dhorda, Chanaki Amaratunga, M. Abul Faiz, Ho Dang Trung Nghia, Nicholas J. White, Nicholas P. J. Day, Arjen M. Dondorp, Joel Tarning   +24 more
wiley   +1 more source